2024-2029 World Immunodiagnostic/Immunoassay Analyzers and Reagents in 98 Countries - 2024 Supplier Shares and Competitive Analysis, 2024-2029 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDM, and Special Chemistry Centralized and POC Tests - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities in Suppliers, Market Challenges and Risks
This new 98-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is available by section, and can be customized to specific information needs and budget.
The report provides a granular strategic analysis of over 55 clinical chemistry assays performed in both centralized (hospitals, commercial laboratories), and POC/decentralized locations. The report explores future market trends; forecasts specimen, test and sales volume; estimates sales and market shares of key suppliers in major countries; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities for reagent and instrument suppliers.
To fit your research budget and receive sections of this report or specific data on geographic regions, countries, markets, companies, technologies and products, select the exact information you need from our In Vitro Diagnostics Database.
Rationale
The clinical chemistry market is undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.
Geographic Regions and Countries
Asia-Pacific
Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam
Europe
Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Kazakhstan, Latvia, Lithuania, Malta, Moldova, Netherlands, Norway, Poland, Portugal, Romania, Russia, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, Ukraine
Latin America
Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
Middle East
Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates
North America
Canada, Mexico, USA
Market Segmentation Analysis
Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers.
Test volume and sales forecasts for over 55 clinical chemistry assays.
Individual Tests Analyzed in the Report
Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea Nitrogen), Calcitonin, Calcium, Carbon Dioxide/Bicarbonate, Cardio hs CRP, Chloride, Cholesterol, Cholinesterase, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Cystatin C, Ferritin, Fructosamine, GGT, Glucose, HDL Cholesterol, Homocysteine, hs-CRP, Insulin, Iron, Iron (Total Binding Capacity), Iron (Unsaturated Binding Capacity), LDH, LDL Cholesterol, LDL Cholesterol Direct, Lipase, Lipoprotein a, Magnesium, Microalbumin, Myoglobin, NT-proBNP, Phosphorus, Potassium, Sodium, ST2, Total Protein, Transferrin, Triglycerides, Troponin, Uric Acid
Current and Emerging Products
Analysis of current and emerging clinical chemistry tests.
Review of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume/POC analyzers.
Technology Review
Assessment of current and emerging technologies, and their potential market applications.
Companies developing or marketing new technologies and products by test.
Strategic Recommendations
New product development opportunities with significant market appeal.
Alternative market penetration strategies.
Potential market entry barriers and risks.
Competitive Assessments
Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D. The companies analyzed in the report include:
Abbott Laboratories
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujifilm Wako
Fujirebio
Grifols
Instrumentation Laboratory/Werfen
Kyowa Medex
PerkinElmer
Quest Diagnostics
QuidelOrtho
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
The report is available by section, and can be customized to specific information needs and budget.
The report provides a granular strategic analysis of over 55 clinical chemistry assays performed in both centralized (hospitals, commercial laboratories), and POC/decentralized locations. The report explores future market trends; forecasts specimen, test and sales volume; estimates sales and market shares of key suppliers in major countries; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities for reagent and instrument suppliers.
To fit your research budget and receive sections of this report or specific data on geographic regions, countries, markets, companies, technologies and products, select the exact information you need from our In Vitro Diagnostics Database.
Rationale
The clinical chemistry market is undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.
Geographic Regions and Countries
Asia-Pacific
Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam
Europe
Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Kazakhstan, Latvia, Lithuania, Malta, Moldova, Netherlands, Norway, Poland, Portugal, Romania, Russia, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, Ukraine
Latin America
Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
Middle East
Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates
North America
Canada, Mexico, USA
Market Segmentation Analysis
Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers.
Test volume and sales forecasts for over 55 clinical chemistry assays.
Individual Tests Analyzed in the Report
Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea Nitrogen), Calcitonin, Calcium, Carbon Dioxide/Bicarbonate, Cardio hs CRP, Chloride, Cholesterol, Cholinesterase, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Cystatin C, Ferritin, Fructosamine, GGT, Glucose, HDL Cholesterol, Homocysteine, hs-CRP, Insulin, Iron, Iron (Total Binding Capacity), Iron (Unsaturated Binding Capacity), LDH, LDL Cholesterol, LDL Cholesterol Direct, Lipase, Lipoprotein a, Magnesium, Microalbumin, Myoglobin, NT-proBNP, Phosphorus, Potassium, Sodium, ST2, Total Protein, Transferrin, Triglycerides, Troponin, Uric Acid
Current and Emerging Products
Analysis of current and emerging clinical chemistry tests.
Review of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume/POC analyzers.
Technology Review
Assessment of current and emerging technologies, and their potential market applications.
Companies developing or marketing new technologies and products by test.
Strategic Recommendations
New product development opportunities with significant market appeal.
Alternative market penetration strategies.
Potential market entry barriers and risks.
Competitive Assessments
Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D. The companies analyzed in the report include:
Abbott Laboratories
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujifilm Wako
Fujirebio
Grifols
Instrumentation Laboratory/Werfen
Kyowa Medex
PerkinElmer
Quest Diagnostics
QuidelOrtho
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
